Matsubara, Japan

Takuya Yasusa




Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Osaka, JP (2002)
  • Matsubara, JP (2010 - 2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takuya Yasusa: Innovator in Optically Active Aminopentane Derivatives

Introduction

Takuya Yasusa is a notable inventor based in Matsubara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active aminopentane derivatives. With a total of 3 patents to his name, Yasusa's work is paving the way for advancements in psychotropic and antidepressant agents.

Latest Patents

Yasusa's latest patents focus on a process for preparing optically active aminopentane derivatives. These derivatives are promising candidates for use as psychotropic agents, antidepressants, antiparkinsonian agents, anti-Alzheimer's agents, and apoptosis inhibitors. His innovative approach includes a novel optically active intermediate oxathiazolidine derivative, which is crucial for the production of the aminopentane derivative. The optically active aminopentane derivatives can be produced in an industrially advantageous manner from this new oxathiazolidine derivative.

Career Highlights

Takuya Yasusa is currently associated with Fujimoto Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has garnered attention for its potential applications in treating various neurological conditions. Yasusa's dedication to innovation is evident in his research and development efforts.

Collaborations

Yasusa collaborates with esteemed colleagues, including Fumio Yoneda and Mayumi Watanabe. Their combined expertise enhances the research and development process, leading to groundbreaking discoveries in the field.

Conclusion

Takuya Yasusa's contributions to the development of optically active aminopentane derivatives highlight his role as a leading inventor in the pharmaceutical industry. His innovative processes and collaborations are set to make a significant impact on the treatment of various mental health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…